Fatty acid, dyslipidaemia and insulin resistance - Preface

Fatty acid, dyslipidaemia and insulin resistance - Preface

Библиографические подробности
Главные авторы:	Karpe, F, Coppack, S
Формат:	Journal article
Опубликовано:	2002

Схожие документы

Journal of the Royal Society of Medicine: Preface
по: Karpe, F, и др.
Опубликовано: (2002)

Fatty acids, obesity, and insulin resistance: time for a reevaluation.
по: Karpe, F, и др.
Опубликовано: (2011)

Metabolic Syndrome: Insulin Resistance, Obesity, Diabetes Mellitus, Hypertension, Physical Activity and Genetic Factors
по: Coppack, S, и др.
Опубликовано: (2008)

Adipose tissue fatty acid metabolism in insulin-resistant men.
по: Bickerton, A, и др.
Опубликовано: (2008)

Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient.
по: Watts, G, и др.
Опубликовано: (2011)

Interaction Among Sex, Aging, and Epigenetic Processes Concerning Visceral Fat, Insulin Resistance, and Dyslipidaemia
по: Ana Arpón, и др.
Опубликовано: (2019-07-01)

Oscillations of fatty acid and glycerol release from human subcutaneous adipose tissue in vivo.
по: Karpe, F, и др.
Опубликовано: (2005)

Insulin plant (Costus pictus) extract improves insulin sensitivity and ameliorates atherogenic dyslipidaemia in fructose induced insulin resistant rats: Molecular mechanism
по: S. Ashwini, и др.
Опубликовано: (2015-08-01)

Fatty acid-induced mitochondrial uncoupling in adipocytes is not a promising target for treatment of insulin resistance unless adipocyte oxidative capacity is increased.
по: Frayn, K, и др.
Опубликовано: (2008)

Republished review: Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient.
по: Watts, G, и др.
Опубликовано: (2011)

Insulin resistance reduces the contribution of systemic plasma non-esterified fatty acids into very low-density lipoprotein triacylglycerol
по: Hodson, L, и др.
Опубликовано: (2007)

Insulin resistance, adipose tissue and coronary heart disease.
по: Frayn, K, и др.
Опубликовано: (1992)

Secondary dyslipidaemia
по: D.J. Blom
Опубликовано: (2011-07-01)

Diabetic dyslipidaemia
по: Subashini C. Thambiah, и др.
Опубликовано: (2021-08-01)

Interaction between specific fatty acids, GLP-1 and insulin secretion in humans.
по: Beysen, C, и др.
Опубликовано: (2002)

The Effect of Omega-3 Fatty Acids on Insulin Resistance
по: Susmita Sinha, и др.
Опубликовано: (2023-06-01)

Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance[S]
по: Myoung Sook Han, и др.
Опубликовано: (2011-06-01)

Association of nonalcoholic fatty liver with carotid intima-media thickness in patients with dyslipidaemia
по: Hamid Dehdashti Shahroukh, и др.
Опубликовано: (2018-09-01)

Dyslipidaemia in endocrine disorders
по: Kalyani Sridharan, и др.
Опубликовано: (2024-03-01)

Treatment of Dyslipidaemia in Children
по: Riccardo Fiorentino, и др.
Опубликовано: (2021-08-01)

Dyslipidaemia in Sri Lanka
по: Anne Thushara Matthias, и др.
Опубликовано: (2022-01-01)

Advances on the treatment of Dyslipidaemias
по: Eleni Bilianou
Опубликовано: (2017-01-01)

Short term fat feeding rapidly increases plasma insulin but does not result in dyslipidaemia
по: Benjamin eBarzel, и др.
Опубликовано: (2014-12-01)

Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study
по: S S Iyengar, и др.
Опубликовано: (2020-01-01)

Truncation of Pik3r1 causes severe insulin resistance uncoupled from obesity and dyslipidaemia by increased energy expenditure
по: Albert Kwok, и др.
Опубликовано: (2020-10-01)

Insulin resistance by adiponectin deficiency: is the action in skeletal muscle?
по: Karpe, F
Опубликовано: (2013)

Adipose tissue fatty acid metabolism in insulin-resistant men (Diabetologia DOI: 10.1007/s00125-008-1040-x)
по: Bickerton, A, и др.
Опубликовано: (2008)

New concepts in the management of dyslipidaemia
по: Baris Gencer, и др.
Опубликовано: (2016-11-01)

Dyslipidaemia in elderly and stroke patients
по: Dhiman Kahali
Опубликовано: (2024-03-01)

Managing dyslipidaemia in young adults
по: Jamshed J. Dalal, и др.
Опубликовано: (2024-03-01)

Role of statins in the management of dyslipidaemia
по: Saumitra Ray
Опубликовано: (2024-03-01)

The changing paradigm of dyslipidaemia management
по: Ruvan Ekanayaka
Опубликовано: (2017-04-01)

Update on the Management of Diabetic Dyslipidaemia
по: Iciar Martín-Timón, и др.
Опубликовано: (2018-11-01)

Adipose tissue function in the insulin-resistance syndrome.
по: Karpe, F, и др.
Опубликовано: (2005)

Omega-3 fatty acids, insulin resistance and type 2 diabetes
по: Leila Azadbakht, и др.
Опубликовано: (2011-01-01)

Insulin and non-esterified fatty acid relations to alimentary lipaemia and plasma concentrations of postprandial triglyceride-rich lipoproteins in healthy middle-aged men.
по: Boquist, S, и др.
Опубликовано: (2000)

Hypertension and Dyslipidaemia in Argentina: Patient Journey Stages
по: Sadler AE, и др.
Опубликовано: (2022-10-01)

Seasonal variation lipid levels in the patients with dyslipidaemia
по: I V Radysh, и др.
Опубликовано: (2009-12-01)

Emerging Strategies for the Management of Atherogenic Dyslipidaemia
по: Anandita Agarwala, и др.
Опубликовано: (2020-02-01)

Established and Emerging Approaches for the Management of Dyslipidaemia
по: Giuseppe Danilo Norata
Опубликовано: (2012-01-01)